Join Now

Author Archives: Denise Bell

Renalytix Announces Leadership Additions for Expanding KidneyIntelX Deployment

By Denise Bell | Published June 11, 2021

RenalytixAI has announced a series of key hires to drive its commercialization strategy in the U.S. market in light of the recently announced Federal Government General Service Administration payment contract and additional large healthcare system partnerships. The combined background and experience of the new leadership team is expected to drive adoption of the KidneyIntelX testing […]

Posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

How St. George Became the Epicenter for a Major Global Genetics Study

By Denise Bell | Published June 11, 2021

The St. George Chamber of Commerce recently held a special luncheon with a presentation by Travis Sheffield, operations director for Intermountain Precision Genomics on “How St. George Became the Epicenter for a Major Global Genetics Study”. Sheffield, who is leading the HerediGene Population Study throughout Utah, Idaho, and soon in Nevada, presented the ins and […]

Posted in BioUtah News, Utah's Life Sciences Companies | Leave a comment

Altitude Lab Launches Investor Coalition to Fund and Mentor Healthcare Startups in Utah

By Denise Bell | Published June 11, 2021

On June 8, Altitude Lab has announced the launch of its Investor Coalition, a partnered network of leading healthcare venture capitalists to fund, mentor, and provide resources for Altitude-incubated startups. Together, the investor coalition aims to collectively invest $50 million in Altitude’s startups over the next three years, specifically supporting diverse and underrepresented founders. In […]

Posted in BioUtah News, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

Senate Passes Endless Frontiers Act to Boost U.S. Innovation

By Denise Bell | Published June 11, 2021

On Tuesday, the U.S. Senate passed the Endless Frontier Act to boost U.S. innovation and out-compete China. The bill passed the Senate by a vote of 68-32. The bill would provide $120 billion to the NSF, DOE and NASA to support research and develoopment in key technology areas critical to our national security, including biotechnology […]

Posted in Policy News | Leave a comment

Scientia Raises $50M to Develop Devices for Stroke, Cancer Treatment

By Denise Bell | Published June 4, 2021

Scientia announced it has raised $50M in growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm. The financing will be used to accelerate sales, marketing, and new product development in both its core neurovascular stroke market as well as adjacent markets in peripheral vascular and interventional oncology. “We are excited […]

Posted in BioUtah News, Industry News, Utah's Life Sciences Companies | Leave a comment

Utah #1 For Best State Economic Outlook…Again

By Denise Bell | Published June 4, 2021

Utah has done it again! The 2021 “Rich States, Poor States” report recently released by the American Legislative Exchange Council (ALEC) ranks Utah as the state with the strongest economic outlook in the nation. Utah has held this first place designation for the past 14 years. View state-by-state data HERE. To determine its rankings, the […]

Posted in BioUtah News, Economic Developments, State News | Leave a comment

Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care

By Denise Bell | Published June 4, 2021

RenalytixA has announced results from a new utility study. The study confirms the importance of risk assessment testing in addressing treatment ambiguity in the early stages of diabetic kidney disease (DKD) and improving patient engagement and adherence – two major barriers to slowing or preventing DKD progression and preserving kidney health. In clinical studies, KidneyIntelX […]

Posted in BioUtah News, Industry News, Utah's Life Sciences Companies | Leave a comment

Known Medicine Shows Its BioHive Pride

By Denise Bell | Published June 4, 2021

Known Medicine is creating the world’s largest purpose-built 3D cell culture data set to predict the best drug for every cancer patient and create the best drug for every cancer. From patient tumor samples the company generates hundreds of micro-tumors on our proprietary platform and treat them with an extensive panel of drugs or drug […]

Posted in BioUtah News | Leave a comment

House Democrats Urge HHS Secretary to Restore FDA Authority of COVID-19 Lab Developed Tests

By Denise Bell | Published May 28, 2021

Last August.under the Trump Administration, HHS announced that FDA would not have premarket review authority and oversight over laboratory developed tests (LDTs), including for COVID-19 tests and EUAs. Recently, House Energy and Commerce Committee Democrats sent a letter to HHS Secretary Becearra uring that he reverse the decision of the previous administration and reinstate FDA […]

Posted in Policy News | Leave a comment

Turner Imaging Systems Receives CE Mark for Smart-C ® Mini C-Arm Portable Fluoroscopy X-Ray Imaging Device

By Denise Bell | Published May 28, 2021

Turner Imaging Systems has received its CE Mark for its Smart-C ® Mini C-Arm portable fluoroscopy x-ray imaging device. This will allow the Smart-C, the world’s first highly portable mini c-arm, to be distributed throughout the EU countries as well as the UK. “Securing the CE Mark is a critical regulatory milestone and major step […]

Posted in BioUtah News, Industry News, Life Sciences Industry News | Leave a comment

Foldax Announces Successful First Human Use of Tria Biopolymer Mitral Heart Valve

By Denise Bell | Published May 28, 2021

Foldax has announced that it has successfully performed the first-in-man Tria Mitral Valve implant. This is another milestone for the Tria LifePolymer valve platform. Strategically, the mitral valve addresses an unmet global need for a more durable mitral valve that doesn’t require lifetime anticoagulants. This is especially important in the many areas where rheumatic fever […]

Posted in BioUtah News | Leave a comment

Xenter, Inc. Continues Rapid Expansion with Appointment of Scott Heuler, SVP of Global Sales and Marketing, and Gary Baldwin as CTO

By Denise Bell | Published May 28, 2021

On the heels of last week’s announcement of the closing of its $12M Series A offering, Xenter, Inc. has announced the appointment of Scott Heuler as Senior Vice President of Global Sales & Marketing and Gary Baldwin as Chief Technology Officer in its Hospital Technologies business unit. Xenter is innovating new wireless technologies and techniques for […]

Posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

A Special Thanks To Our Elite Members